Our quantitative RT‐PCR and Western blotting experiments showed that the expression of CD90 was also significantly down‐regulated by knockdown of Gli1 and Gli3 expression in CD90+ liver cancer cells (Figure 4A,B). The gene discussed is GLI1; the disease is liver cancer.